| Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver disease SC Huang, HJ Su, JH Kao, TC Tseng, HC Yang, TH Su, PJ Chen, CJ Liu Gut and liver 15 (3), 451, 2021 | 53 | 2021 |
| Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives SC Huang, CJ Liu Clinical and Molecular Hepatology 29 (2), 320, 2023 | 45 | 2023 |
| Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B SC Huang, TH Su, TC Tseng, CL Chen, SJ Hsu, SH Liao, CM Hong, ... Hepatology International 17 (5), 1139-1149, 2023 | 34 | 2023 |
| Hepatitis B reactivation: diagnosis and management SC Huang, HC Yang, JH Kao Expert Review of Gastroenterology & Hepatology 14 (7), 565-578, 2020 | 25 | 2020 |
| Metabolic dysfunction-associated steatotic liver disease facilitates hepatitis B surface antigen seroclearance and seroconversion SC Huang, TH Su, TC Tseng, CL Chen, SJ Hsu, CH Liu, SH Liao, ... Clinical Gastroenterology and Hepatology 22 (3), 581-590. e6, 2024 | 21 | 2024 |
| Metabolic dysfunction-associated fatty liver disease and chronic hepatitis B SC Huang, JH Kao Journal of the Formosan Medical Association 121 (11), 2148-2151, 2022 | 16 | 2022 |
| Risk of hepatitis b virus (HBV) reactivation in HBsAg-negative, anti-HBc-Negative patients receiving rituximab for autoimmune diseases in HBV endemic areas TY Lan, YC Lin, TC Tseng, HC Yang, JH Kao, CF Cheng, TJ Lee, ... Gut and Liver 17 (2), 288, 2022 | 15 | 2022 |
| Direct comparison of biopsy techniques for hepatic malignancies SC Huang, JD Liang, SJ Hsu, TC Hong, HC Yang, JH Kao Clinical and Molecular Hepatology 27 (2), 305, 2020 | 12 | 2020 |
| Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents SC Huang, PN Cheng, CH Liu, HC Yang, TH Su, TC Tseng, PJ Chen, ... Journal of the Formosan Medical Association 121 (5), 920-929, 2022 | 11 | 2022 |
| The interplay between chronic hepatitis B and diabetes mellitus: A narrative and concise review SC Huang, JH Kao The Kaohsiung Journal of Medical Sciences 40 (1), 6-10, 2024 | 7 | 2024 |
| Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma SC Huang, SH Liao, TH Su, YM Jeng, JH Kao Hepatology International 15, 472-481, 2021 | 7 | 2021 |
| Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resection TH Su, SC Huang, CL Chen, SJ Hsu, SH Liao, CM Hong, TC Tseng, ... Journal of the Formosan Medical Association 122 (10), 1008-1017, 2023 | 5 | 2023 |
| Serum Mac-2 binding protein glycosylation isomer to predict the severity of hepatic fibrosis in patients with hepatitis C virus infection CH Liu, CJ Liu, TH Su, SC Huang, TC Tseng, JH Wu, PJ Chen, JH Kao Diagnostics 12 (11), 2650, 2022 | 4 | 2022 |
| Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infection CH Liu, PN Cheng, YJ Fang, CY Chen, WY Kao, CL Lin, SS Yang, ... Journal of Hepatology, 2024 | 3 | 2024 |
| Impact of metabolic disorders on chronic hepatitis B SC Huang, CJ Liu, JH Kao Clinical Liver Disease 23 (1), e0130, 2024 | 3 | 2024 |
| Pre-existing and new-onset metabolic dysfunctions increase cirrhosis and its complication risks in chronic hepatitis B SC Huang, TH Su, TC Tseng, SH Liao, SJ Hsu, CM Hong, TY Lan, CH Liu, ... Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022 | 3 | 2022 |
| hepatic steatosis and fibrosis in chronic hepatitis B—the chicken‐and‐egg conundrum. SC Huang, JH Kao Alimentary Pharmacology & Therapeutics 55 (1), 2022 | 3 | 2022 |
| Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct … CH Liu, YP Chang, YJ Fang, PN Cheng, CY Chen, WY Kao, CL Lin, ... Journal of Gastroenterology, 1-12, 2024 | 2 | 2024 |
| Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy KC Chang, TH Su, SH Liao, TC Tseng, SC Huang, SJ Hsu, CM Hong, ... Journal of the Formosan Medical Association, 2024 | 2 | 2024 |
| Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease FP Tsai, TH Su, SC Huang, TC Tseng, SJ Hsu, SH Liao, CM Hong, CH Liu, ... Cancer, 2024 | 2 | 2024 |
